Home › NDC Lookup › RxCUI directory › RxCUI 244642

Dimethicone 20 MG/ML Topical Cream — RxCUI 244642

Name: Dimethicone 20 MG/ML Topical Cream (RxCUI 244642)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 244642 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI244642

Official nameDimethicone 20 MG/ML Topical Cream

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asdimethicone 2 % Topical Cream

FDA products mapped5

Package NDCs mapped7

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Dimethicone 20 MG/ML Topical Cream Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Dimethicone 20 MG/ML Topical Cream RxCUI 244642 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Dimethicone 324072 IN
Brand names 2

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Mederma PM 1442976 BN
- Mederma Stretch Mark Therapy 1483137 BN
Dose forms 8

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Dimethicone Topical Cream 377680 SCDF
- Dimethicone Topical Product 1159485 SCDG
- Dimethicone Topical Cream [Mederma PM] 1442978 SBDF
- Dimethicone Topical Cream [Mederma Stretch Mark Therapy] 1483139 SBDF
- Mederma PM Topical Product 1442979 SBDG
- Mederma Stretch Mark Therapy Topical Product 1483140 SBDG
- Topical Cream 316982 DF
- Topical Product 1151122 DFG
Clinical & branded drugs 5

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Dimethicone 20 MG/ML 358435 SCDC
- Dimethicone 20 MG/ML Topical Cream [Mederma PM] 1442980 SBD
- Dimethicone 20 MG/ML Topical Cream [Mederma Stretch Mark Therapy] 1483141 SBD
- Dimethicone 20 MG/ML [Mederma PM] 1442977 SBDC
- Dimethicone 20 MG/ML [Mederma Stretch Mark Therapy] 1483138 SBDC
Packs 1

Fixed collections of drugs packaged and sold together, like dose packs.
- {1 (118 ML) (dimethicone 20 MG/ML Topical Cream) / 1 (80000 MG) (triamcinolone acetonide 1 MG/ML Topical Cream) } Pack 1720617 GPCK

Showing up to 8 concepts per family — 17 of 17 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Dimethicone 20 MG/ML SCDC · 358435
Dimethicone Topical Cream SCDF · 377680
Dimethicone Topical Product SCDG · 1159485
{1 (118 ML) (dimethicone 20 MG/ML Topical Cream) / 1 (80000 MG) (triamcinolone acetonide 1 MG/ML Topical Cream) } Pack GPCK · 1720617

Brand-Name Concepts

Dimethicone 20 MG/ML Topical Cream [Mederma PM] SBD · 1442980
Dimethicone 20 MG/ML Topical Cream [Mederma Stretch Mark Therapy] SBD · 1483141
Dimethicone 20 MG/ML [Mederma PM] SBDC · 1442977
Dimethicone 20 MG/ML [Mederma Stretch Mark Therapy] SBDC · 1483138
Dimethicone Topical Cream [Mederma PM] SBDF · 1442978
Dimethicone Topical Cream [Mederma Stretch Mark Therapy] SBDF · 1483139
Mederma PM Topical Product SBDG · 1442979
Mederma Stretch Mark Therapy Topical Product SBDG · 1483140
Mederma PM BN · 1442976
Mederma Stretch Mark Therapy BN · 1483137

📦 FDA Products & Package NDCs

5 products · 7 package NDCs

7 package NDCs map to RxCUI 244642 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00113-4124-64	1 TUBE in 1 CARTON (0113-4124-64) / 28 g in 1 TUBE (0113-41...	Mederma PM	L Perrigo Company	2026-03-05
62654-0144-04	118 mL in 1 BOTTLE, PLASTIC (62654-144-04)	BOA VIDA Canopy	Central Solutions Inc	2011-11-01
62654-0144-05	148 mL in 1 BOTTLE, PLASTIC (62654-144-05)	BOA VIDA Canopy	Central Solutions Inc	2011-11-01
68828-0004-01	1 TUBE in 1 CARTON (68828-004-01) / 30 mL in 1 TUBE	Royal Jelly Scar Balm	Distribuidora Comercial Jafra, S.A. de C.V.	2022-06-15
73302-0203-28	1 TUBE in 1 BOX (73302-203-28) / 28 g in 1 TUBE	Mederma PM	HRA PHARMA AMERICA, INC.	2020-10-01
73302-0203-48	1 JAR in 1 BOX (73302-203-48) / 48 g in 1 JAR	Mederma PM	HRA PHARMA AMERICA, INC.	2020-10-01
73302-0204-15	1 TUBE in 1 BOX (73302-204-15) / 150 g in 1 TUBE	Mederma Stretch Marks Therapy	HRA PHARMA AMERICA, INC.	2020-10-01

Observed labelers: HRA PHARMA AMERICA, INC. (3) · Central Solutions Inc (2) · Distribuidora Comercial Jafra, S.A. de C.V. (1) · L Perrigo Company (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.